Compass for Patient Access
Find the rightpatient assistance program
for your patients
My Patient Solutions connects your office with ours. We’re available online to help you with access and reimbursement whenever a Genentech medicine is prescribed. It’s the most efficient way to work with Genentech Access Solutions to get your patients on therapy as soon as possible.
My Patient Solutions helps you manage patient access from enrollment to treatment.
Prescriber electronic signatures and scanned document attachments allow for a completely paperless patient enrollment process.
Your patients’ full benefits investigation (BI) reports are uploaded to My Patient Solutions in real time so you can know exactly what is covered before beginning treatment.
Search for patient cases initiated via fax or through My Patient Solutions for easier patient case management.
Request refills for GATCF prescriptions online via My Patient Solutions to avoid interruption in therapy.
Get alerts (eg, Statement of Medical Necessity form expiring in 30 days) to learn what actions you should take to connect your patients to their medicine. You can opt to receive these alerts via email as well.
You will need the following information in order to successfully register your practice:
You are then asked to agree to the My Patient Solutions Practice Agreement. You must agree to these terms to proceed with My Patient Solutions.
Daily administration of Pulmozyme Inhalation Solution in conjunction with standard therapies is indicated in the management of cystic fibrosis (CF) patients to improve pulmonary function. In patients with an FVC ≥40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics. Safety and efficacy of daily administration have not been demonstrated in patients for longer than 12 months.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
Please see full prescribing information for Pulmozyme, including additional Important Safety Information.